Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

OLIG2 anticorps

OLIG2 Reactivité: Humain WB, ELISA, IHC, ICC Hôte: Souris Monoclonal 1G11 unconjugated
N° du produit ABIN969331
  • Antigène Voir toutes OLIG2 Anticorps
    OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))
    Reactivité
    • 64
    • 43
    • 42
    • 6
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 73
    • 10
    • 1
    Souris
    Clonalité
    • 64
    • 20
    Monoclonal
    Conjugué
    • 45
    • 7
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp OLIG2 est non-conjugé
    Application
    • 51
    • 37
    • 21
    • 14
    • 13
    • 13
    • 13
    • 11
    • 7
    • 5
    • 4
    • 4
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunocytochemistry (ICC)
    Purification
    purified
    Immunogène
    Purified recombinant fragment of human OLIG2 expressed in E. coli.
    Clone
    1G11
    Isotype
    IgG1
    Top Product
    Discover our top product OLIG2 Anticorps primaire
  • Indications d'application
    ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000, ICC: 1:200 - 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    4°C, -20°C for long term storage
  • Bonnet-Dupeyron, Combes, Boespflug-Tanguy, Vaurs-Barrière: "Absence of OLIG2 mutations in patients presenting with a severe Pelizaeus-Merzbacher-like leukodystrophy associated with motor neuron dysfunction." dans: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, Vol. 147B, Issue 4, pp. 538-9, (2008) (PubMed).

    Mikami, Hirose, Yoshida, Kawase, Ohnishi, Nagashima, Mukai, Okada, Ikeda: "Predominant expression of OLIG2 over ID2 in oligodendroglial tumors." dans: Virchows Archiv : an international journal of pathology, Vol. 450, Issue 5, pp. 575-84, (2007) (PubMed).

  • Antigène
    OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))
    Autre désignation
    OLIG2 (OLIG2 Produits)
    Synonymes
    anticorps olig3.2, anticorps MGC89336, anticorps OLIG2, anticorps BHLHB1, anticorps OLIGO2, anticorps PRKCBP2, anticorps RACK17, anticorps bHLHe19, anticorps wu:fc64g09, anticorps AI604895, anticorps Bhlhb1, anticorps Olg-2, anticorps Oligo2, anticorps RK17, anticorps oligodendrocyte transcription factor 4, anticorps oligodendrocyte transcription factor 2, anticorps oligodendrocyte lineage transcription factor 2, anticorps olig4, anticorps OLIG2, anticorps Olig2, anticorps olig2
    Sujet

    Description: This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14,21)(q11.2,q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. Tissue specificity: Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas highly variable.

    Aliases: BHLHB1, OLIGO2, RACK17, PRKCBP2, bHLHe19, OLIG2

    Poids moléculaire
    32 kDa
    ID gène
    10215
    HGNC
    10215
Vous êtes ici:
Support technique